Sanofi, GSK say Covid-19 vaccine won't be ready until late 2021
Drugmakers Sanofi and GlaxoSmithKline said Friday that their potential COVID-19 vaccine won't be ready until late next year because they need to improve the shot's effectiveness in older people.
A warning from AstraZeneca that initial supplies of its Europe-bound Covid-19 vaccines will be lower than expected has sparked new concern over the rollout of inoculations, with some countries planning for a sharp drop in deliveries. Dr. Anthony Fauci says the AstraZeneca and Johnson and Johnson COVID-19 vaccines could be headed toward emergency use authorization in weeks, not months. Dr. Leo Nissola joined CBSN's Anne-Marie Green and Vladimir Duthiers to discuss the vaccine rollout around the country and the Biden administration's ambitious plan to give 100 million doses in 100 days.
CBSN is CBS News' 24/7 digital streaming news service featuring live, anchored coverage available for free across all platforms. Launched in November 2014, the service is a premier destination for breaking news and original storytelling from the deep bench of CBS News correspondents and reporters. CBSN features the top stories of the day as well as deep dives into key issues facing the nation and the world. CBSN has also expanded to launch local news streaming services in major markets across the country. CBSN is currently available on CBSNews.com and the CBS News app across more than 20 platforms, as well as the CBS All Access subscription service. Amid rising COVID-19 cases and deaths, pharmaceutical companies are able to act fast on a COVID-19 vaccine by pivoting vaccine technologies that have already been used or are in development. VP Mike Pence touted President Trump's leadership during a roundtable discussion on the COVID-19 vaccine and Operation Warp Speed on Thursday.